Sale!

Mycoplasma Pneumonia RNA Detection Qualitative Test Cost

Original price was: 1,440 د.إ.Current price is: 1,220 د.إ.

-15%

The Mycoplasma Pneumonia RNA Detection Qualitative Test is a diagnostic tool utilized to identify the presence of Mycoplasma pneumoniae RNA in a patient’s sample, typically obtained from respiratory secretions. This pathogen is a common cause of community-acquired pneumonia, particularly in children and young adults, leading to symptoms ranging from mild respiratory issues to more severe pneumonia. The test employs nucleic acid amplification techniques, such as PCR (Polymerase Chain Reaction), to qualitatively assess the presence of the RNA of the bacteria, offering a highly sensitive and specific method for detecting active infections.

Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic services, the test is priced at 1220 AED. The cost reflects the sophisticated technology and expertise required to accurately identify the RNA of Mycoplasma pneumoniae, ensuring reliable results for patients and healthcare providers. By opting for this test, individuals suspected of having a Mycoplasma pneumoniae infection can receive a prompt and precise diagnosis, facilitating timely and appropriate treatment interventions.

Description

Mycoplasma Pneumonia RNA Detection Qualitative Test

Cost: AED 1220.0

Symptoms, Diagnosis, and Test Details:

The Mycoplasma pneumonia (RNA detection) qualitative test is a diagnostic test used to detect the presence of RNA from the bacteria Mycoplasma pneumoniae in a patient’s respiratory sample. This test is typically performed using a polymerase chain reaction (PCR) technique.

Mycoplasma pneumoniae is a common cause of respiratory infections, particularly in children and young adults. It is responsible for causing a type of pneumonia known as “atypical pneumonia” or “walking pneumonia.” Traditional diagnostic methods, such as bacterial culture, are time-consuming and may not always yield accurate results. Therefore, the RNA detection test has become a preferred method for diagnosing Mycoplasma pneumoniae infections.

During the test, a respiratory sample, such as a throat swab or sputum sample, is collected from the patient. The sample is then processed in the laboratory to extract the RNA present in the sample. The RNA is then converted into complementary DNA (cDNA) using reverse transcription. PCR is then performed to amplify the specific regions of the Mycoplasma pneumoniae RNA.

If the RNA from Mycoplasma pneumoniae is present in the sample, the PCR will generate a positive result, indicating the presence of the bacteria. Conversely, a negative result suggests the absence of Mycoplasma pneumoniae RNA in the sample.

The Mycoplasma pneumonia (RNA detection) qualitative test is a rapid and accurate method for diagnosing Mycoplasma pneumoniae infections. It allows for early detection and appropriate treatment of the infection, leading to improved patient outcomes.

Components: Price – AED 1220.0

Sample Condition: Bronchoalveolar lavage fluids and throat swabs, Endo cervical swab, Blood, Urine, CSF, Serum, Plasma

Report Delivery: 3rd Working Day (Email – 36 hours, On phone – 24 hours)

Method: Real Time PCR

Test Type: Viral

Doctor: Physician

Test Department: Genetics

Pre Test Information: Need to sign Consent document and bring any clinical history of patient for Mycoplasma Pneumonia (RNA Detection) Qualitative Test

Test Name	Mycoplasma Pneumonia RNA Detection Qualitative Test
Components
Price	1220.0 AED
Sample Condition	Bronchoalveolar lavage fluids and throat swabsEndo cervical swab, Blood, Urine, CSF, Serum, Plasma.
Report Delivery	3rd Working Day Email:-36 hours.On phone: 24 hours
Method	Real Time PCR
Test type	Viral
Doctor	Physician
Test Department:	Genetics
Pre Test Information	Need to sign Consent document and bring any clinical history of patient forMycoplasma Pneumonia (RNA Detection) QualitativeTest
Test Details	The Mycoplasma pneumonia (RNA detection) qualitative test is a diagnostic test used to detect the presence of RNA from the bacteria Mycoplasma pneumoniae in a patient’s respiratory sample. This test is typically performed using a polymerase chain reaction (PCR) technique. Mycoplasma pneumoniae is a common cause of respiratory infections, particularly in children and young adults. It is responsible for causing a type of pneumonia known as “atypical pneumonia” or “walking pneumonia.” Traditional diagnostic methods, such as bacterial culture, are time-consuming and may not always yield accurate results. Therefore, the RNA detection test has become a preferred method for diagnosing Mycoplasma pneumoniae infections. During the test, a respiratory sample, such as a throat swab or sputum sample, is collected from the patient. The sample is then processed in the laboratory to extract the RNA present in the sample. The RNA is then converted into complementary DNA (cDNA) using reverse transcription. PCR is then performed to amplify the specific regions of the Mycoplasma pneumoniae RNA. If the RNA from Mycoplasma pneumoniae is present in the sample, the PCR will generate a positive result, indicating the presence of the bacteria. Conversely, a negative result suggests the absence of Mycoplasma pneumoniae RNA in the sample. The Mycoplasma pneumonia (RNA detection) qualitative test is a rapid and accurate method for diagnosing Mycoplasma pneumoniae infections. It allows for early detection and appropriate treatment of the infection, leading to improved patient outcomes.